These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33295607)

  • 1. The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Melo FJ; Pinto-Lopes P; Estevinho MM; Magro F
    Inflamm Bowel Dis; 2021 Jun; 27(7):1153-1165. PubMed ID: 33295607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury.
    Matheeussen V; Jungraithmayr W; De Meester I
    Pharmacol Ther; 2012 Dec; 136(3):267-82. PubMed ID: 22850530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress.
    Lei Y; Yang G; Hu L; Piao L; Inoue A; Jiang H; Sasaki T; Zhao G; Yisireyili M; Yu C; Xu W; Takeshita K; Okumura K; Kuzuya M; Cheng XW;
    Int J Cardiol; 2017 Sep; 243():413-420. PubMed ID: 28549747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases.
    Hu X; Wang X; Xue X
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.
    Vallon V; Docherty NG
    Exp Physiol; 2014 Sep; 99(9):1140-5. PubMed ID: 25085841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
    Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
    J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.
    Avogaro A; Fadini GP
    Diabetes Care; 2014 Oct; 37(10):2884-94. PubMed ID: 25249673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.
    Zhong J; Rao X; Rajagopalan S
    Atherosclerosis; 2013 Feb; 226(2):305-14. PubMed ID: 23083681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.
    Elmansi AM; Awad ME; Eisa NH; Kondrikov D; Hussein KA; Aguilar-Pérez A; Herberg S; Periyasamy-Thandavan S; Fulzele S; Hamrick MW; McGee-Lawrence ME; Isales CM; Volkman BF; Hill WD
    Pharmacol Ther; 2019 Jun; 198():90-108. PubMed ID: 30759373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.
    Bank U; Bohr UR; Reinhold D; Lendeckel U; Ansorge S; Malfertheiner P; Tager M
    Front Biosci; 2008 May; 13():3699-713. PubMed ID: 18508466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.
    Huang J; Liu X; Wei Y; Li X; Gao S; Dong L; Rao X; Zhong J
    Front Immunol; 2022; 13():830863. PubMed ID: 35309368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
    Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH
    Salaga M; Binienda A; Draczkowski P; Kosson P; Kordek R; Jozwiak K; Fichna J
    Peptides; 2018 Oct; 108():34-45. PubMed ID: 30179653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.
    Wang A; Dorso C; Kopcho L; Locke G; Langish R; Harstad E; Shipkova P; Marcinkeviciene J; Hamann L; Kirby MS
    BMC Pharmacol; 2012 Apr; 12():2. PubMed ID: 22475049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studies.
    Zhong J; Kankanala S; Rajagopalan S
    Curr Opin Lipidol; 2016 Oct; 27(5):484-92. PubMed ID: 27472408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.